Skip to content

The Impact of Daily Sinus Irrigation on Nasal Symptoms in Continuous Positive Airway Pressure (CPAP) Users - A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01121445
Enrollment
30
Registered
2010-05-12
Start date
2010-05-31
Completion date
2011-03-31
Last updated
2010-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Sleep apnea, CPAP, Saline irrigation

Brief summary

Continuous positive airway pressure (CPAP) is the most commonly used treatment for obstructive sleep apnea. Nasal symptoms such as dryness, itching and congestion are common in CPAP users. Nasal and sinus saline irrigation has been shown to improve these symptoms in individuals with chronic nasal congestion and sinusitis. This is an 8 week study that investigates whether daily saline nasal and sinus irrigation reduces nasal symptoms in patients using CPAP, improves quality of life and CPAP compliance.

Interventions

DEVICENeilMed nose and sinus irrigation

Saline irrigation used daily plus CPAP with heated humidification for 4 weeks

Sponsors

NeilMed Pharmaceuticals
CollaboratorINDUSTRY
Bridgeport Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 * Apnea/hypopnea index ≥ 10 * A documented successful CPAP titration

Exclusion criteria

* Conditions that in the judgment of the investigator would interfere with subject participation in the study * History of sinus or nasal surgery * History of psychiatric illness * Use of sleep aids, sedatives or narcotics * Use of oral of subcutaneous anti-coagulants (i.e. warfarin, enoxaparin) * Bilevel or other nocturnal ventilation other than CPAP * Use of supplemental oxygen * Pregnancy or lactating * Inability or unwillingness to provide informed consent * Inability to perform baseline measurements * Inability to be contacted by phone

Design outcomes

Primary

MeasureTime frameDescription
RQLQ (Rhinoconjunctivitis Quality of Life Questionnaire)4 weeksA 28-item, self administered questionnaire measuring nasal symptoms and other domains, including activity limitations and eye symptoms. Subjects will be asked to rate their symptoms on a 7-point scale (0=no impairment, 6=severely impaired). Change in RQLQ with daily saline irrigation in CPAP users is the primary outcome of interest.

Secondary

MeasureTime frameDescription
Epworth Sleepiness Scale4 weeksThe Epworth Sleepiness Scale is a self administered questionnaire that measures subjective daytime hypersomnia on a scale of 0 to 24.
SF-364 weeksThe Medical Outcome Study 36-Item Short Form health survey (SF-36) is a 36-item questionnaire which measures 8 domains of health: physical functioning, physical problems, emotional problems, social functioning, mental health, energy/vitality, pain, and general perception of health status. This questionnaire has been used as a validated measure of change in the quality of life of OSA patients on CPAP therapy.
CPAP compliance4 weeksCPAP card compliance data will be measured to determine if use of daily sinus rinse is associated with an increase in CPAP use. The % of days CPAP used over 4 weeks and the average number of hours of CPAP use per night are the outcomes of interest.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026